Development of a Quality Appraisal Tool for Systematic Literature Reviews of Studies Eliciting Health State Utility Values (HSUVs): A Delphi Consensus Approach

Author(s)

Muchadeyi M1, Hernandez-Villafuerte K2, Di Tanna GL3, Eckford R1, Feng Y4, Meregaglia M5, Peasgood T6, Petrou S7, Ubels J1, Schlander M1
1German Cancer Research Center (DKFZ), Heidelberg, BW, Germany, 2WifOR Institute, Darmstadt , HE, Germany, 3University of Applied Sciences and Arts of Southern Switzerland, Manno, Lugano, Switzerland, 4Queen Mary University of London, London, UK, 5Bocconi School of Management,, Milan, Lombardy, Italy, 6University of Melbourne, Melbourne, VIC, Australia, 7University of Oxford, Oxford, South East England, UK

OBJECTIVES: Cost-effectiveness analyses have proven highly sensitive to the health state utility value (HSUV) selection. With an uptick in studies eliciting HSUVs, systematic literature reviews (SLRs) and meta-analyses have become essential tools to synthesize these studies in various decision contexts. Therefore, quality appraisal (QA) of HSUV elicitation studies is central to informing new health technology assessments. This study aimed to develop a scientifically grounded, evidence-based QA tool tailored to SLRs of studies eliciting HSUVs.

METHODS: We adopted a comprehensive mixed-methods approach. Initially, a rapid review was performed to identify terminologies related to scientific quality, QA, QA dimensions, QA items, and signaling questions used in SLRs of studies eliciting HSUVs. This was followed by a Delphi consensus process involving an international, multidisciplinary expert panel, which completed two rounds of online questionnaires and an online panel discussion on QA aspects in HSUVs. The consensus was defined a priori at all stages of the Delphi study.

RESULTS: 73 SLRs were included, and seven international experts participated in the Delphic study. Response rates to the questionnaire's first and second rounds and the virtual meeting were 7/7, 6/7 and 5/7, respectively. Consensus was reached on the definitions of scientific quality, QA, three QA dimensions, the scope of the QA tool, QA items for reporting quality, study relevance, methodological limitations and risk of bias. The panel also ranked the most critical items for QA of studies eliciting HSUVs. The first version of the Quality Appraisal Tool - Health Sates Utility Values (QAT-HSUV) was developed.

CONCLUSIONS: The proposed QA tool, specific for studies eliciting HSUVs, discerns between reporting, relevance, and methodological quality. The consensus achieved on definitions, QA dimensions, and the scope of a QA tool marks a significant step towards standardizing the QA process for HSUVs. The next steps will involve the assessments of the tool's usability, validity and discriminant ability.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

PCR270

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×